TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
BioInvent International AB
Closing information (x1000 DKK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
47,999
|
217,928
|
14,095 |
Financial expenses |
1,026
|
531
|
521 |
Earnings before taxes |
-221,720
|
-28,402
|
-202,465 |
EBITDA |
-248,481
|
-34,027
|
-202,397 |
Total assets |
940,465
|
1,144,158
|
1,052,385 |
Current assets |
761,185
|
724,406
|
811,492 |
Current liabilities |
50,992
|
58,349
|
42,750 |
Equity capital |
879,710
|
1,073,264
|
993,979 |
- share capital |
8,840
|
8,683
|
8,503 |
Employees (average) |
104
|
89
|
79 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
93.5%
|
93.8%
|
94.5% |
Turnover per employee |
462
|
2,449
|
178 |
Profit as a percentage of turnover |
-461.9%
|
-13.0%
|
-1436.4% |
Return on assets (ROA) |
-23.5%
|
-2.4%
|
-19.2% |
Current ratio |
1492.8%
|
1241.5%
|
1898.2% |
Return on equity (ROE) |
-25.2%
|
-2.6%
|
-20.4% |
Change turnover |
-171,052
|
204,975
|
-93,064 |
Change turnover % |
-78%
|
1582%
|
-87% |
Chg. No. of employees |
15
|
10
|
7 |
Chg. No. of employees % |
17%
|
13%
|
10% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.